TrumpRx vs. The Great Healthcare Plan | Which Will Lower Your Costs First? | Simplefill

TrumpRx is available right now and delivering real discounts to a specific slice of the population — but the Great Healthcare Plan is a legislative framework that hasn’t passed Congress yet and may be a year or more away from changing what you actually pay. If you’re uninsured or paying out of pocket for expensive medications today, understanding which initiative actually helps you — and on what timeline — matters more than the headlines.

What Is TrumpRx and How Does It Work?

TrumpRx launched on February 5, 2026 as a federal government website at TrumpRx.gov. It doesn’t sell medications directly — instead, it functions as a portal that directs patients to pharmaceutical manufacturers’ websites where they can purchase specific drugs at pre-negotiated cash prices significantly below the standard retail list price.

The platform launched with discounts on 40 of the most expensive and commonly prescribed brand-name drugs in the country. Some of the price reductions are genuinely dramatic:​

• Ozempic (semaglutide injectable): dropped from $1,028/month to as low as $199 depending on dosage​

• Wegovy (injectable): dropped from $1,349/month to an average of $350​

• Wegovy (oral pill): dropped from $1,349/month to as low as $149​

• Bevespi Aerosphere (COPD inhaler): dropped from $458 to $51/month​

• Cetrotide (fertility): dropped from $316 to $22.50​

These discounts are the product of Most-Favored-Nation (MFN) pricing agreements that the Trump administration began negotiating in May 2025, eventually reaching deals with 16 major pharmaceutical manufacturers by the end of 2025.​

Who Does TrumpRx Actually Help?

This is the most important question to ask before getting too excited about the headlines — and the honest answer is: a specific subset of patients, not the majority.

TrumpRx is designed for cash-paying, uninsured patients and those whose medications aren’t covered by their insurance plan. If that describes your situation, the discounts are meaningful and accessible today. However, several groups are explicitly excluded or unlikely to benefit:​

• Medicare and Medicaid enrollees cannot use TrumpRx — participants in any government-funded prescription drug benefit are ineligible​

• Insured patients using their pharmacy benefits will almost always pay less through their plan than through TrumpRx cash prices — and critically, TrumpRx purchases do NOT count toward annual deductibles or out-of-pocket maximums​

• Patients near their out-of-pocket maximum would lose significant protection by switching to cash pay, since insurers cover 100% of costs once the cap is hit​

According to STAT News analysis, TrumpRx realistically benefits approximately 15% of Americans — those with no or marginal prescription drug coverage. For the other 85%, existing insurance benefits remain cheaper in most cases.​

That said, for patients in the uninsured 15% — which includes many of Simplefill’s members — any reduction from full list price is meaningful, and TrumpRx prices are a genuine improvement over the pre-deal retail baseline. The question is whether they’re the best option available, or whether patient assistance programs can do even better.

How Does TrumpRx Compare to Manufacturer Patient Assistance Programs?

Here’s the comparison most patients don’t know to make. Before TrumpRx existed, uninsured patients could already access many of these same brand-name medications for free — not at a discount, but at no cost at all — through manufacturer patient assistance programs (PAPs).

The New York Times noted pointedly that for individuals without any health insurance, “manufacturers provide these drugs for free or at significantly reduced rates” through existing PAP infrastructure. That dynamic didn’t change when TrumpRx launched.​

The practical takeaway:

For uninsured patients who qualify for a PAP — typically those earning under certain income thresholds with a valid prescription and no government drug coverage — a free medication through Simplefill’s medication assistance program is a better financial outcome than a discounted cash price through TrumpRx. The distinction is income and eligibility: TrumpRx has no income test, while PAPs do. If you don’t qualify for a PAP, TrumpRx is a meaningful step down from full retail.

What Is the Great Healthcare Plan?

The Great Healthcare Plan is a legislative framework President Trump called on Congress to enact on January 15, 2026. It is broader in scope than TrumpRx and addresses not just drug prices but the entire structure of healthcare affordability — but it requires Congressional action to become law, which means it operates on a fundamentally different timeline than a White House website.

The plan’s core components include:

• Codifying MFN pricing — making the voluntary manufacturer pricing agreements already negotiated into permanent law, locking in the discounts currently accessible through TrumpRx across all channels, not just cash pay​

• Restoring and restructuring ACA premium subsidies — the enhanced ACA subsidies that kept premiums affordable for marketplace enrollees expired at the end of 2025, affecting approximately 22 million people; the Great Healthcare Plan proposes to replace them and cut premiums on popular ACA plans by an average of 10–15%

• Eliminating broker and middleman kickbacks — targeting the insurance broker compensation structures that Trump’s plan argues drive up premiums​

• Funding the Cost Sharing Reduction program — a long-underfunded ACA provision that would reduce out-of-pocket costs (not just premiums) for lower-income marketplace enrollees​

• Maximizing price transparency — requiring hospitals, insurers, and pharmacy benefit managers to disclose true negotiated prices​

The Kaiser Family Foundation noted that the plan “leaves open key questions” including details on out-of-pocket costs, coverage for people with pre-existing conditions, and total federal spending impact.​

What’s the Real Timeline on the Great Healthcare Plan?

This is where patients paying bills today need to be clear-eyed. The Great Healthcare Plan is a proposal, not a law. As of late February 2026, it has not been passed by Congress, and legislative analysts note that it is uncertain whether Congress will act on it this year at all.​

Policy experts and healthcare law firms monitoring the situation describe the plan as a “framework” — a statement of intent and direction rather than an enacted set of rules patients can rely on now. Even if Congress takes up and passes the legislation quickly, the implementation of new insurance rules, premium structures, and codified drug pricing typically follows enactment by months or years of regulatory rulemaking.​

The honest answer to “which will lower your costs first” is: TrumpRx already has, for uninsured cash-pay patients on the 40 covered drugs. The Great Healthcare Plan, if enacted, would eventually be far more impactful — it would benefit insured patients too, codify pricing across all purchase channels, and restore ACA coverage for millions — but “eventually” is the operative word.

What Should Uninsured Patients Do Right Now?

Given the current landscape, here’s the practical priority order for an uninsured patient struggling to afford their medications today:

1. Check if you qualify for a manufacturer PAP first. If your income qualifies and you have a valid prescription, free medication through a PAP beats a discounted cash price every time. Simplefill’s prescription assistance program handles the entire research, application, and enrollment process for you.

2. Check TrumpRx for your specific medications. If you don’t qualify for a PAP — either because your income is above the threshold or your drug isn’t covered by one — TrumpRx cash prices are now meaningfully lower than retail list prices for the 40 drugs currently on the platform. Visit TrumpRx.gov, identify your drug, and compare the cash price to what you’re currently paying.

3. Don’t use TrumpRx if you’re insured and near your out-of-pocket maximum. The savings calculation changes dramatically once you factor in the loss of deductible and OOP max credit. Run the numbers with your pharmacist before switching to cash pay.

4. Monitor the Great Healthcare Plan’s progress — particularly the ACA subsidy restoration component if you buy marketplace insurance. If Congress acts, the premium cuts could be significant.

5. Ask about alternatives if your drug isn’t on TrumpRx or a PAP. Simplefill researches therapeutic alternatives that may have assistance available when your specific medication doesn’t. That option is part of every standard Simplefill enrollment.

The Bottom Line for Patients Who Can’t Wait on Congress

Policy proposals don’t fill prescriptions. If you are uninsured, paying out of pocket, or paying more than you can manage for a chronic condition medication right now, the fastest path to relief isn’t TrumpRx or the Great Healthcare Plan — it’s a phone call to Simplefill.

Get Affordable Access to Prescription Medications

Simplefill is a full-service prescription assistance company that maintains patients’ enrollment in all sources of assistance available to them.

Apply today by calling 877-386-0206. A representative will contact you within 24 hours.

Frequently Asked Questions

Can I use TrumpRx if I have Medicaid or Medicare?

No. TrumpRx is strictly a direct-to-consumer (DTC) platform for cash-paying patients.

• The Rule: You are not eligible for TrumpRx coupons if you are enrolled in any government-funded program, including Medicare Part D, Medigap, Medicaid, the VA, or TRICARE.

• The Alternative: Many Medicare and Medicaid beneficiaries are now seeing costs capped through separate federal agreements (such as the $50 monthly cap for GLP-1s) rather than through this website.

Does using TrumpRx count toward my insurance deductible?

No. Purchases made through TrumpRx are considered “out-of-network” cash payments.

• Important Warning: Dollars spent here do not count toward your private insurance deductible or your annual out-of-pocket maximum.

• Check First: If you have a high-deductible plan and expect to hit your limit this year, using your insurance (even at a higher initial price) might save you more money in the long run than using TrumpRx.

Is the “Great Healthcare Plan” already law?

No. As of February 24, 2026, it remains a legislative proposal.

• Current Status: President Trump formally called on Congress to enact the plan on January 15, 2026.

• What it aims to do: If passed, it would codify “Most-Favored-Nation” (MFN) pricing into law, eliminate PBM kickbacks, and move certain prescription drugs to over-the-counter (OTC) status. For now, the savings on TrumpRx are based on voluntary agreements with manufacturers, not new laws.

Which drugs are currently on TrumpRx?

The platform launched with roughly 43 high-cost branded medications. Key categories include:

• Weight Loss/Diabetes: Ozempic, Wegovy (injectable and oral), Zepbound, and Trulicity.

• Respiratory: Inhalers like Airsupra, Advair Diskus, and Bevespi Aerosphere.

• Fertility: Gonal-F, Cetrotide, and Ovidrel.

• Other: Repatha (cholesterol), Mayzent (MS), and various insulins.

Note: TrumpRx does not sell these drugs directly; it provides coupons or links to manufacturer-owned pharmacies like LillyDirect.

What happens if the Great Healthcare Plan doesn’t pass?

Uninsured patients are still protected by the voluntary MFN agreements already signed by 16 major manufacturers (including Pfizer, Eli Lilly, and AstraZeneca). These agreements established the current TrumpRx prices and remain in effect regardless of the Congressional vote. Simplefill’s advocacy services also operate independently of any new legislation.